SEC Form 4 · accession 0001104659-15-022118
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Georges Gemayel
Director
Period of report
Mar 23, 2015
Accepted (ET)
Mar 24, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $11.46 | Mar 23, 2015 | A | 35,000 | A | Mar 23, 2016 | Mar 23, 2025 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on March 23, 2016.